Sunday, January 13, 2019 1:03:10 AM
@Verus_Foods
4h4 hours ago
Finally, this 14C should not be feared or judged in isolation, as with it nothing negative as happened. No dilution and no reverse. We are working to avoid dilution at the low price and market cap. We look forward to laying out our game plan in greater detail in our next update
Once we have completed these structural issues, we intend to close on our first M&A prospect within a very short time frame.
We cont. to have high expectations for 2019. We are nearing completion of our negotiations with note holders and have already completed successful negotiations with potential funding sources. We have one final, issue to resolve, which will be our top priority in the coming week.
Our goal is only to engage in dilution when it is offset by enhanced growth or profitability that creates shareholder value.
In particular, M&A activity often includes shares, and we anticipate to become increasingly larger. We do not have an equity offering planned at this time and these shares are not intended for existing obligations...
The increase in authorized is also done for planning purposes and is in excess of any anticipated needs. We may need shares available in the future for actions such as institutional debt, uplisting liquidity & M&A activity, so this total is sufficiently large to cover co’s needs.
For companies such as Verus, the significant costs (around $10,000) associated with filing a 14C make it prudent to include multiple future actions to save the expense of multiple filings. So, the reverse authorization was included here for that reason alone...
Accordingly, we want to assure investors that there is no reverse split planned at this time. We intend to only use the reverse split when our market cap qualifies us for institutional investment and/or in conjunction with an uplist to a listed exchange...
We want to clear up some misconceptions that have surfaced concerning the recently filed Schedule 14C. First off, investors should understand that a 14C is used for planning purposes and can include measures that are not scheduled and may not happen until the distant future...
https://twitter.com/Verus_Foods/with_replies
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM